Mycosis Fungoides
📧 Sign up to get email alerts when something new happens for Mycosis Fungoides.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides [Phase 2]
A Phase 2 clinical trial is evaluating ultra-low-dose radiation therapy for patients with Mycosis fungoides, including localized skin lesion…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of VG712 in Patients With Mycosis Fungoides [Phase 2]
Phase 2 study update for VG712 in mycosis fungoides; the trial is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and in combination with ipilimumab, nivolumab…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers [Phase 2]
This Phase 2 clinical trial update evaluates the combination of talimogene laherparepvec (T-VEC) and nivolumab for patients with refractory …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma [Phase 1]
This clinical trial update discusses MEDI-570, an anti-ICOS monoclonal antibody, in relapsed or refractory peripheral T-cell lymphoma follic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome [Phase 1]
Phase 1 clinical trial evaluating the combination of duvelisib and nivolumab for stage IIb–IVB mycosis fungoides and Sézary syndrome; trial …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma [Phase 1]
A Phase 1 clinical trial is evaluating intravenous vesicular stomatitis virus in patients with peripheral T-cell lymphoma and related condit…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides [Phase 1]
This clinical trial update describes a Phase 1 study evaluating mogamulizumab and brentuximab vedotin in patients with cutaneous T-cell lymp…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL [Phase 3]
A Phase 3 confirmatory study of topical HyBryte versus placebo for cutaneous T-cell lymphoma (CTCL) is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL) [Phase 1]
A Phase 1 clinical trial is evaluating CCR4-directed CAR T cells in CCR4-expressing mature T-cell malignancies, including peripheral T-cell …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides [Phase 1]
Phase 1 trial evaluating the safety of combining Bexarotene with radiotherapy in patients with Mycosis Fungoides, a form of cutaneous T-cell…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
The update describes a clinical trial evaluating long-term outcomes in juvenile-onset mycosis fungoides and lymphomatoid papulosis, which is…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides [Phase 2]
Phase 2 clinical trial evaluating the combination of ultra-low-dose total-skin electron beam therapy with Brentuximab Vedotin given quarterl…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas [Phase 2]
Phase 2 clinical trial update evaluating pembrolizumab with mogamulizumab in advanced-stage, relapsed/refractory cutaneous T-cell lymphoma, …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL [Phase 1]
Phase 1 study of CAR-T cells targeting CD30 and CCR4 for relapsed/refractory CD30+ Hodgkin lymphoma and cutaneous T-cell lymphoma, with the …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
This clinical trial update indicates ongoing recruitment for a University of Pittsburgh study collecting blood, urine, and tissue samples fr…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
A clinical trial update notes ongoing recruitment for systemic therapies in the treatment of cutaneous T-cell lymphoma, including mycosis fu…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy [NA]
A completed clinical trial update investigates interleukin-35 as a key immunosuppressive driver in mycosis fungoides and how phototherapy mo…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas [Phase 2]
Clinical trial update indicates a Phase 2 study of the JAK1 inhibitor golidocitnib for relapsed/refractory indolent T- and NK-cell lymphomas…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
This Stanford University clinical trial aims to identify prognostic factors in Mycosis fungoides and Sézary syndrome and is currently recrui…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of extracorporeal photopheresis and mogamulizumab for erythrodermic cutaneous T-cell lymphoma, curr…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Photopheresis in Early-stage Mycosis Fungoides [Phase 2]
Phase 2 trial evaluating photopheresis in early-stage mycosis fungoides (cutaneous T cell lymphoma) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of ST-001 nanoFenretinide for relapsed/refractory T-cell non-Hodgkin lymphoma is currently recruiting, targeting multiple T-ce…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
A clinical trial update on mogamulizumab (Poteligeo) assessing safety and efficacy through use-result surveillance in patients with mycosis …
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy [Phase 4]
Phase 4 update evaluating KW-0761 (mogamulizumab) for Mycosis fungoides or Sézary syndrome in Chinese patients who have previously received …